HomePHGUF • OTCMKTS
Pharming Group NV
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 92.67M | 14.10% |
Operating expense | 68.73M | -23.12% |
Net income | 2.86M | 191.55% |
Net profit margin | 3.08 | 180.00% |
Earnings per share | 0.01 | 225.00% |
EBITDA | 19.43M | 351.07% |
Effective tax rate | 57.19% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 167.89M | -21.33% |
Total assets | 399.99M | -13.58% |
Total liabilities | 178.92M | -26.69% |
Total equity | 221.06M | — |
Shares outstanding | 683.93M | — |
Price to book | 2.81 | — |
Return on assets | 7.11% | — |
Return on capital | 8.55% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 2.86M | 191.55% |
Cash from operations | 9.33M | -19.40% |
Cash from investing | -9.79M | -150.51% |
Cash from financing | -2.20M | -116.08% |
Net change in cash | -5.72M | -180.67% |
Free cash flow | 5.58M | 266.33% |
Previous close
$0.90
Year range
$0.75 - $1.07
Market cap
514.63M EUR
Avg Volume
5.88K
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
About
Founded
1988
Website
Employees
426
